Pier Capital, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$10,803,000
+5.7%
61,065
-3.5%
1.12%
+9.4%
Q2 2021$10,217,000
+34.9%
63,251
+43.0%
1.02%
+42.6%
Q1 2021$7,575,000
+27.3%
44,218
+63.2%
0.72%
+14.0%
Q4 2020$5,950,000
+36.5%
27,090
+3.2%
0.63%
-0.9%
Q3 2020$4,358,000
-45.3%
26,245
-62.4%
0.64%
-50.1%
Q2 2020$7,965,000
+66.4%
69,766
+12.0%
1.28%
+20.4%
Q1 2020$4,787,00062,2721.06%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders